Global Policy and Advocacy Landscape on Menopause: A Global Comparative Review and Analysis

Main Article Content

Okiomiteni Joy Olufuye
Saheed Akinmayowa Lawal
Adegboyega Moses Oyefabi

Abstract

Background: Menopause is the permanent end of menstruation and fertility which occur as a natural part of ageing, typically between ages 45 and 55. Medically it is described as a point in time one year after the last menstrual period due to loss of ovarian follicular function and declining estrogen. With about 1.2 billion expected to be menopausal by 2030 and 47million transitioning annually, menopause is a critical intersection between economic sustainability and public health. Yet, inclusion in global national health strategies remains inadequate and fragmented.


Method: This manuscript review and compares maturity of menopause-specific policy and advocacy across the globe. Comparative evaluation of clinical and legislative frameworks between high income countries and Low- and Middle-Income Countries (LMICs) on menopause was done using the Multi-Level Governance Maturity Framework (MLG).


Results: The Result showed critical maturity disparity as high-income nations have good levels of clinical and workplace legislative frameworks, while low- and middle-income nations have policy gaps and inequity between rural and urban areas.


Conclusion: Formulating menopause-specific health policies with the Sustainable Development Goals (SDGs) can change the current invisibility and increase economic growth as well as quality of life, especially in LMICs.


 


 

Downloads

Download data is not yet available.

Article Details

Section

Review Articles

How to Cite

Olufuye, O. . ., Lawal, S. ., & Oyefabi, A. (2026). Global Policy and Advocacy Landscape on Menopause: A Global Comparative Review and Analysis. The Nigerian Health Journal, 26(2), 853 – 867. https://doi.org/10.71637/tnhj.v26i2.1399

References

1. Mishra GD, Santoro N. The changing face of menopause: Global perspectives and clinical challenges. J Clin Endocrinol Metab. 2023;108(4):815-824.

2. Santoro N, Roeca C, Peters BA, Neal-Perry G. The menopause transition: signs, symptoms, and management options. The Journal of Clinical Endocrinology & Metabolism. 2021 Jan 1;106(1):1-5.

3. Tandon VR, Sharma S, Mahajan A, Mahajan A, Tandon A. Menopause and sleep disorders. Journal of mid-life health. 2022 Jan 1;13(1):26-33.

4. World Health Organization. Menopause: Key facts [Internet]. Geneva: World Health Organization; 2022 [cited 2026 Mar 14]. Available from: https://www.who.int/news-room/fact-sheets/detail/menopause

5. Monteleone P, Mascagni G, Giannini A, Genazzani AR, Simoncini T. Symptoms of menopause — global prevalence, physiology and implications. Nat Rev Endocrinol. 2022;14(4):199-215.

6. Anolue FC, Onwere S, Ezirim G, Onwere A. Sociocultural perceptions of menopause among women in South Eastern Nigeria. Afr J Reprod Health.

7. Makinde OA, Adeyemi AS. Health-seeking behavior and use of alternative medicine for menopausal symptoms in rural West Africa. Int J Gynaecol Obstet. 2024;164(1):45-52.

8. Nosek M, Kennedy HP, Beyene Y, Taylor D, Gilliss C, Lee K. The effects of perceived stress and attitudes toward menopause and aging on symptoms of menopause. Journal of midwifery & women's health. 2010 Jul 1;55(4):328-34.

9. Islam RM, Rana J, Katha S, Hossain MA, Salekin SU, Chowdhury AT, Kabir A, Romero L, Davis SR. Menopause in low and middle-income countries: a scoping review of knowledge, symptoms and management. Climacteric. 2025 May 4;28(3):242-79.

10. Avis NE, Crawford SL, Greendale G, Bromberger JT, Everson-Rose SA, Gold EB, Hess R, Joffe H, Kravitz HM, Tepper

11. Kaye DK, Kakaire O, Osinde MO. Availability of medical attention for menopause and its inclusion in national health strategies in low-resource settings. Int J Gynecol Obstet. 2020;148(1):125–131.

12. Hickey M, Hunter MS, Santoro N, Ussher J. Normalising menopause. bmj. 2022 Jun 15;377.

13. House of Commons Women and Equalities Committee. Menopause and the workplace. London: UK Parliament; 2022.

14. Dalingwater L, Winett L. “A Duty of Care”: National Policy Discourse Regarding Menopause, Well-Being, and the Workplace. The Journal of Aging and Social Change. 2025;15(1):53.

15. World Health Organization. Research on the menopause in the 1990s. Geneva: WHO; 2000. (WHO Technical Report Series, No. 866).

16. Sibanda-Moyo N, Zvinavashe M, Haruzivishe C. Menopause education in primary care: A strategic necessity for improving women’s health outcomes in sub-Saharan Africa. Afr J Reprod Health. 2021;25(4):88–96.2021;151:37-43.

17. Hardy C, Griffiths A, Hunter MS. Closing the gap in workplace support for women experiencing menopause. Occup Med. 2019;69(8):577–579

18. International Menopause Society. Global consensus recommendations on menopause in the workplace. Climacteric. 2021;24(6):531–540.

19. Babalola EO, Okunlola MA, Aimakhu CO. Integration of menopausal services into primary healthcare: The Nigerian challenge. Niger J Med. 2023;32(1):12–18

20. United Nations (UN). (2015). Transforming our world: the 2030 Agenda for Sustainable Development

21. World Health Organization. Health education and promotion guidance. Geneva: WHO; 2013

22. United Nations Statistics Division. SDG indicators database. New York: United Nations; 2023.

23. Field-Springer K, Reece C, Randall-Griffiths D. Intergenerational considerations for educators and healthcare providers who assist girls and women transitioning through menarche and menopause. Women's Reproductive Health. 2019 Apr 3;6(2):79-101.

24. Cowell AC, Gilmour A, Atkinson D. Support mechanisms for women during menopause: perspectives from social and professional structures. Women. 2024 Mar 8;4(1).

25. Lin L, Feng P, Yu Q. Attitude and knowledge for menopause management among health professionals in mainland China. Climacteric. 2020 Nov 1;23(6):614-21.

26. Keye C, M M, Mm S, M OD. Menopause education of healthcare professionals: A scoping review protocol. PLoS One. 2025;20(11):e0325012

27. Rees M, Bitzer J, Cano A, Ceausu I, Chedraui P, Durmusoglu F, Erkkola R, Geukes M, Godfrey A, Goulis DG, Griffiths A. Global consensus recommendations on menopause in the workplace: a European Menopause and Andropause Society (EMAS) position statement. Maturitas. 2021 Sep 1;151:55-62.

28. Braveman P, Gruskin S. Defining equity in health. Journal of Epidemiology & Community Health. 2003 Apr 1;57(4):254-8.

29. Richard-Davis G, Singer A, King DD, Mattle L. Understanding attitudes, beliefs, and behaviors surrounding menopause transition: results from three surveys. Patient related outcome measures. 2022 Dec 31:273-86.

30. Waughray A, Davidson C, O'Dempsey D. Menopause discrimination in the Workplace: do the protected characteristics of sex, age and disability provide sufficient Protection? Briefings. 2022 Jul 1; 76:5-13.

31. Waldman EG, Cahn NR, Crawford BJ. Contextualizing menopause in the law. Harv. JL & Gender. 2022;45:1.

32. Cahn N, Crawford BJ, Waldman EG. Menopause discrimination at work: Comparing the law in the United States and United Kingdom. InResearch Handbook on Law, Society and Ageing 2024 Aug 15 (pp. 281-297). Edward Elgar Publishing.

33. Liss J, Chesnokova A, Allen JT. Unspoken and untaught: addressing the gap in menopause education. Current Obstetrics and Gynecology Reports. 2024 Dec;13(4):281-8.

34. Gold EB. The timing of the age at which natural menopause occurs. Obstetrics and gynecology clinics of North America. 2011 Sep;38(3):425.

35. Talaulikar V, Takhar J. Menopause in transition: science, equity, and the future of care. Journal of Marketing Management. 2025 Feb 12;41(3-4):388-94.

36. Jack G, Riach K, Bariola E, Pitts M, Schapper J, Sarrel P. Menopause in the workplace: what employers should be doing. Maturitas. 2016 Mar 1;85:88-95.

37. Bariola E, Jack G, Pitts M, Riach K, Sarrel P. Employment conditions and work-related stressors are associated with menopausal symptom reporting among perimenopausal and postmenopausal women. Menopause. 2017 Mar 1;24(3):247-51.

38. Wood K, McCarthy S, Pitt H, Randle M, Arnot G, Thomas SL. “Hiding symptoms and balancing work, family and relationships”: Australian women discuss menopause and the midlife collision. Social Science & Medicine. 2025 Oct 14:118681.

39. Kirby J. Silent women sufferers: experiences of menopause in 1970s Britain. Journal of Women's History. 2025;37(1):80-99.

40. Hunter M, Rendall M. Bio-psycho-socio-cultural perspectives on menopause. Best practice & research Clinical obstetrics & gynaecology. 2007 Apr 1;21(2):261-74.

41. Wakefield MA, Loken B, Hornik RC. Use of mass media campaigns to change health behaviour. The lancet. 2010 Oct 9;376(9748):1261-71.

42. Thurston RC, Joffe H. Vasomotor symptoms and menopause: findings from the Study of Women’s Health across the Nation. Obstetrics and gynecology clinics of North America. 2011 Sep;38(3):489.

43. Mählmann L, Reumann M, Evangelatos N, Brand A. Big data for public health policy-making: policy empowerment. Public health genomics. 2018 Apr 4;20(6):312-20.

44. Islam RM, Rana J, Katha S, Hossain MA, Salekin SU, Chowdhury AT, Kabir A, Romero L, Davis SR. Menopause in low and middle-income countries: a scoping review of knowledge, symptoms and management. Climacteric. 2025 May 4;28(3):242-79.8.

45. Barbazza E, Tello JE. A review of health governance: definitions, dimensions and tools to govern. Health policy. 2014 May 1;116(1):1-1.

46. World Health Organization. Everybody’s business: Strengthening health systems to improve health outcomes: WHO’s framework for action [Internet]. Geneva: WHO; 2007 [cited 2026 Mar 17]. Available from: https://www.who.int/publications/i/item/978924159607

47. World Health Organization. Menopause [Internet]. Geneva: WHO; 2024 Oct 17 [cited 2026 Mar 17]. Available from: https://www.who.int/news-room/fact-sheets/detail/menopause

48. Panay N, Ang SB, Cheshire R, Goldstein SR, Maki P, Nappi RE, International Menopause Society Board. Menopause and MHT in 2024: addressing the key controversies–an International Menopause Society White Paper. Climacteric. 2024 Sep 2;27(5):441-57.

49. Griffiths A, Ceausu I, Depypere H, Lambrinoudaki I, Mueck A, Pérez-López FR, Van Der Schouw YT, Senturk LM, Simoncini T, Stevenson JC, Stute P. EMAS recommendations for conditions in the workplace for menopausal women. Maturitas. 2016 Mar 1;85:79-81.

50. Sit W. Age of renewal: an occupational therapy workshop for women in perimenopause (Doctoral dissertation, Boston University).

51. Shifren JL, Gass ML, NAMS Recommendations for Clinical Care of Midlife Women Working Group. The North American Menopause Society recommendations for clinical care of midlife women. Menopause. 2014 Oct 1;21(10):1038-62.

52. Al-Saleh Y, Al-Daghri NM, Sabico S, Alessa T, Al Emadi S, Alawadi F, Al Qasaabi S, Alfutaisi A, Al Izzi M, Mukhaimer J, Suhaili AR. Diagnosis and management of osteoporosis in postmenopausal women in Gulf Cooperation Council (GCC) countries: consensus statement of the GCC countries’ osteoporosis societies under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Archives of osteoporosis. 2020 Dec;15(1):109.

53. Delanerolle G, Phiri P, Elneil S, Talaulikar V, Eleje GU, Kareem R, Shetty A, Saraswath L, Kurmi O, Benetti-Pinto CL, Muhammad I. Menopause: a global health and wellbeing issue that needs urgent attention. The Lancet Global Health. 2025 Feb 1;13(2):e196-8.

54. Howe D, Duffy S, O’Shea M, Hawkey A, Wardle J, Gerontakos S, Steele L, Gilbert E, Owen L, Ciccia D, Cox E. Policies, guidelines, and practices supporting women’s menstruation, menstrual disorders and menopause at work: A critical global scoping review. InHealthcare 2023 Nov 10 (Vol. 11, No. 22, p. 2945). MDPI.

55. Maggetti M, Trein P. Multilevel governance and problem‐solving